Door-to-unload time and mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock
Abstract
BACKGROUND
Microaxial flow pumps (mAFPs) provide left ventricular unloading and haemodynamic stabilisation, with evidence suggesting a survival benefit in patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock (CS). The prognostic impact of early mAFP placement after hospital arrival remains unclear. Aims: We aimed to investigate the association between door-to-unload time and in-hospital mortality in patients with STEMI-CS. Methods: We analysed data from the Japan Registry for Percutaneous Ventricular Assist Devices, including consecutive patients with STEMI-CS who underwent mAFP placement between February 2020 and December 2023. The primary outcome was in-hospital mortality. Results: Among 1,783 patients, the median door-to-unload time was 99 min. The overall in-hospital mortality rate was 39.2%, and this increased with longer door-to-unload times: 32.9% (≤60 min), 33.0% (61-90 min), 40.1% (91-150 min), and 48.3% (>150 min). Using a 90 min cutoff, delayed placement (>90 min) was associated with higher mortality (adjusted odds ratio 1.56, 95% confidence interval: 1.26-1.95). A restricted cubic spline model showed that mortality remained stable when placement was within 90 min, followed by an increase. When stratified by no prior mechanical circulatory support and prior venoarterial extracorporeal membrane oxygenation (VA-ECMO) only, the patients with prior VA-ECMO only had more severe baseline characteristics and higher mortality;…
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.